ACRS
Aclaris Therapeutics Inc. Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$1.535
Kõrge
$1.535
Madal
$1.535
Maht
0.61M
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika
Seotud uudised
Aclaris Therapeutics to Participate in Two June Healthcare Conferences
WAYNE, Pa., May 28, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today
Wedbush Initiates Coverage On Aclaris Therapeutics with Outperform Rating, Announces Price Target of $8
Wedbush analyst Martin Fan initiates coverage on Aclaris Therapeutics with a Outperform rating and announces Price Target of $8.
HC Wainwright & Co. Maintains Buy on Aclaris Therapeutics, Lowers Price Target to $16
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Aclaris Therapeutics with a Buy and lowers the price target from $20 to $16.
Aclaris Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
- Multiple Catalysts in Immuno-Inflammatory Indications Anticipated in 2025 and 2026 - - Expected Cash Runway Extended Through the First Half of 2028 - - Phase 2 Results Received to Date from Chinese Partner CTTQ
Seotud aktsiad
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.